CAPLIPOINT CAPLIN POINT LABORATORIES LTD.
Healthcare
LTP
2,222.15
CHG · %
-28.25 (-1.26%)
VOL · TODAY
76.90K
PREV CLOSE
2,250.4
Today's range2,191.55 · 2,262.4
2,222.15
52-week range1,500.3 · 2,990
2,222.15
Loading candles…
Caplin Point Laboratories Ltd, incorporated in 1990, is an Indian pharmaceutical company operating primarily through a 100% export-oriented business model. The company engages in manufacturing and sourcing active pharmaceutical ingredients (APIs), finished pharmaceutical formulations including ointments and creams, as well as research and development and clinical research. It owns distribution networks and focuses on serving markets in Latin America, Francophone Africa, the USA, Canada, Australia, Mexico, Brazil, and other countries. Caplin Point has a dominant presence in Latin America and Francophone Africa and is expanding its footprint in regulated markets such as the USA, Canada, Australia, Mexico, and Brazil. Its approach combines ownership of distribution networks with targeting the Bottom of the Pyramid market segment within the pharmaceutical industry.
CAPLIPOINT is not part of any active scan today.
This page is a live market overview for CAPLIN POINT LABORATORIES LTD. (CAPLIPOINT) on the BSE. As a listed security, CAPLIN POINT LABORATORIES LTD. is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for CAPLIPOINT before placing trades on tick2trade.
As of the latest feed, CAPLIPOINT last traded at ₹2,222.15 on BSE, down ₹28.25 (1.26%) from the previous close of ₹2,250.4. Today's session range is ₹2,191.55 – ₹2,262.4, against a 52-week band of ₹1,500.3 – ₹2,990. Traded volume today stands at 76.90K shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for CAPLIPOINT in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether CAPLIPOINT is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for CAPLIN POINT LABORATORIES LTD. before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in CAPLIPOINT. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated CAPLIPOINT option chain page linked from this overview.
// similar in healthcare325 total